Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23988461 | 0.87 | PAOX (0.32) | PAOX | |
| SCHEMBL23988457 | 0.87 | PAOX (0.33) | PAOXEPHX2 | |
| SCHEMBL23988530 | 0.86 | PAOX (0.31) | PAOX | |
| SCHEMBL23988453 | 0.81 | APP (0.42) | APPEPHX2 | |
| SCHEMBL16666053 | 0.81 | APP (0.50) | APP | |
| SCHEMBL7108955 | 0.81 | APP (0.50) | APPPAOXEPHX2 | |
| SCHEMBL28256664 | 0.77 | APP (0.46) | APPPAOXEPHX2 | |
| SCHEMBL918312 | 0.76 | APP (0.50) | APPPAOXEPHX2 | |
| SCHEMBL11238895 | 0.75 | APP (0.41) | APP | |
| SCHEMBL739439 | 0.75 | APP (0.41) | APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210340404-A1 | SILANOL COMPOSITIONS AND METHODS OF USE | 3M INNOVATIVE PROPERTIES COMPANY | 2021-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210340404-A1 | SILANOL COMPOSITIONS AND METHODS OF USE | EPCAM, ITGA8, CD99 | APP 3050/4885PAOX 3439/4885EPHX2 479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.